BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 38131270)

  • 1. E = mc
    Rezaei SJ; Cissé FA; Touré ML; Duan R; Rice DR; Ham AS; de Walque D; Mateen FJ
    Epilepsia Open; 2024 Feb; 9(1):445-454. PubMed ID: 38131270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, severity, and associations of depression in people with epilepsy in Guinea: A single-center study.
    Sylla M; Vogel AC; Bah AK; Tassiou NR; Barry SD; Djibo BA; Toure ML; Foksona S; Konaté M; Cisse FA; Mateen FJ
    Epilepsy Behav; 2020 Dec; 113():107475. PubMed ID: 33189054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Socioeconomic associations of poorly controlled epilepsy in the Republic of Guinea: cross-sectional study.
    Rice DR; Sakadi F; Tassiou NR; Vogel AC; Djibo Hamani AB; Bah AK; Garcia A; Patenaude BN; Fode Cisse A; Mateen FJ
    Trop Med Int Health; 2020 Jul; 25(7):813-823. PubMed ID: 32324940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England.
    Raspin C; Shankar R; Barion F; Pollit V; Murphy J; Sawyer L; Danielson V
    J Med Econ; 2021; 24(1):1037-1051. PubMed ID: 34348576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retention, efficacy, tolerability, and quality of life during long-term adjunctive brivaracetam treatment by number of lifetime antiseizure medications: A post hoc analysis of phase 3 trials in adults with focal seizures.
    Brandt C; Dimova S; Elmoufti S; Laloyaux C; Nondonfaz X; Klein P
    Epilepsy Behav; 2023 Jan; 138():108967. PubMed ID: 36435010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between cognitive impairment and antiseizure medication adherence among people with epilepsy in Addis Ababa, Ethiopia.
    Mamo B; Feyissa AM; Mengesha T; Ayele BA; Mamushet Yifru Y
    Epilepsy Behav; 2024 Mar; 152():109651. PubMed ID: 38295505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a free medication intervention on seizure recurrence and anxious and depressive symptoms in people living with epilepsy in the Republic of Guinea.
    Rice DR; Guelngar CO; Traoré M; Condé ML; Diallo D; Lee NJ; Ham AS; Cissé FA; Mateen FJ;
    Trop Med Int Health; 2024 Jan; 29(1):33-41. PubMed ID: 38031206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survey on the worldwide availability and affordability of antiseizure medications: Report of the ILAE Task Force on Access to Treatment.
    Pironi V; Ciccone O; Beghi E; Paragua-Zuellig H; Patel AA; Giussani G; Bianchi E; Venegas V; Vigevano F;
    Epilepsia; 2022 Feb; 63(2):335-351. PubMed ID: 34981508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cluster-randomized trial comparing home-based primary health care and usual clinic care for epilepsy in a resource-limited country.
    Singh G; Sharma S; Bansal N; Sharma M; Chowdhury A; Sharma S; Bansal RK; Goraya JS; Setia RK; Paul BS; Sander JW
    Epilepsia Open; 2022 Dec; 7(4):781-791. PubMed ID: 36213959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional cash transfers to retain rural Kenyan women in the continuum of care during pregnancy, birth and the postnatal period: protocol for a cluster randomized controlled trial.
    Ochieng CA; Haghparast-Bidgoli H; Batura N; Odhiambo A; Shannon G; Copas A; Palmer T; Dickin S; Noel S; Fielding M; Onyango S; Odera S; Eleveld A; Mwaki A; Vanhuyse F; Skordis J
    Trials; 2019 Mar; 20(1):152. PubMed ID: 30823886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatments for seizures in catamenial (menstrual-related) epilepsy.
    Maguire MJ; Nevitt SJ
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013225. PubMed ID: 34528245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States.
    Raspin C; Faught E; Armand J; Barion F; Pollit V; Murphy J; Danielson V
    J Med Econ; 2023; 26(1):189-199. PubMed ID: 36691763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of adjunctive cenobamate based on number of concomitant antiseizure medications, seizure frequency, and epilepsy duration at baseline: A post-hoc analysis of a randomized clinical study.
    Rosenfeld WE; Nisman A; Ferrari L
    Epilepsy Res; 2021 May; 172():106592. PubMed ID: 33662894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in seizure risk increases from antiseizure medication withdrawal among patients with well-controlled epilepsy: A pooled analysis.
    Terman SW; Slinger G; Koek A; Skvarce J; Springer MV; Ziobro JM; Burke JF; Otte WM; Thijs RD; Lossius MI; Marson AG; Bonnett LJ; Braun KPJ
    Epilepsia Open; 2024 Feb; 9(1):333-344. PubMed ID: 38071463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilisation of specialist epilepsy services and antiseizure medication adherence rates in a cohort of people with epilepsy (PWE) accessing emergency care.
    Taha M; Hanif S; Dickson G; Todd J; Fyfe D; MacBride-Stewart S; Hassett R; Marshall AD; Heath CA
    Seizure; 2024 Feb; 115():59-61. PubMed ID: 38184899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II randomised placebo-controlled trial of sodium selenate as a disease-modifying treatment in chronic drug-resistant temporal lobe epilepsy: the SeLECT study protocol.
    Vivash L; Johns H; Churilov L; MacPhail S; Casillas-Espinosa P; Malpas C; Shultz SR; Tailby C; Wijayath M; Reutens D; Gillinder L; Perucca P; Carney P; Nicolo JP; Lawn N; Kwan P; Velakoulis D; Hovens CM; O'Brien TJ
    BMJ Open; 2023 Oct; 13(10):e075888. PubMed ID: 37890967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-seizure medications for neonates with seizures.
    Abiramalatha T; Thanigainathan S; Ramaswamy VV; Pressler R; Brigo F; Hartmann H
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD014967. PubMed ID: 37873971
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.